It has long been reported that biomarkers, including ER, PR, HER2, and tumor grade, correlate with prognosis [17,18,19,20]; the AJCC recently published a prognostic staging system that incorporates this concept [2]. The gene discussed is ESR1; the disease is neoplasm.